Denise Lau

EY Entrepreneurial Winning Women™ Asia-Pacific Class of 2025
Executive Director and Chief Operating Officer,
OrbusNeich Medical Group Holdings Limited, Greater China

Denise Lau serves as the Executive Director and COO of OrbusNeich Medical Group Holdings Limited, a major global medical device manufacturer. Based in Hong Kong, China, the company specializes in devices for interventional procedures, such as percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA). OrbusNeich's products are now available in over 70 countries and regions, expanding into neurovascular intervention and structural heart disease markets.

Since joining OrbusNeich in 2018 as Chief Legal Counsel and Senior Vice President of Group Business Development, Denise has been pivotal in the company's resurgence. She redefined its goals and streamlined operations, leading it to sustainability. She secured a record US$200 million in financing, the largest in China's medical sector for that year, and guided OrbusNeich's successful IPO on the Hong Kong Stock Exchange, raising US$61.7 million.

Denise's commitment to innovation and team collaboration has positioned OrbusNeich for continued success in the medical device market. With over two decades of experience in investment and law, she earned her Law degree from the University of Hong Kong and a Master's in International Economic Law from the University of Warwick.

The company now has a global footprint across 70 countries. Denise is determined to position the company as a global leader in medical devices, extending its reach to 80 countries and regions and increasing market share with an expanded product line. In the next three years, OrbusNeich plans significant investments in R&D and production, including a new Hangzhou facility, while pursuing global expansion and maintaining sustainable, patient-centered practices.